Outset Medical (OM) Liabilities and Shareholders Equity (2019 - 2026)

Outset Medical (OM) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $249.5 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 17.18% year-over-year to $249.5 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 8.82% decrease from a year earlier, with the FY2025 full-year figure at $264.5 million, down 4.1% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $249.5 million, down from $264.5 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for OM reached as high as $431.7 million in Q1 2022 and fell as low as $249.5 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $325.2 million across 5 years, with a median of $313.8 million in 2023.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 13.67% in 2022 and fell as far as 25.18% in 2022.
• Year by year, Liabilities and Shareholders Equity stood at $400.1 million in 2022, then declined by 21.57% to $313.8 million in 2023, then decreased by 12.11% to $275.8 million in 2024, then declined by 4.1% to $264.5 million in 2025, then decreased by 5.69% to $249.5 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $249.5 million in Q1 2026, $264.5 million in Q4 2025, and $277.3 million in Q3 2025.